Overview
Prognostic indicators for patients with Candida spp. bloodstream infections
Antifungal pharmacokinetics/pharmacodynamics
Immunogenetics among patients with candidiasis
Management of the HIV infected patient and antiretroviral pharmacotherapy
Antibacterial drug utilization, resistance, and appropriate prescribing
Antimicrobial Stewardship
Antifungal pharmacokinetics/pharmacodynamics
Immunogenetics among patients with candidiasis
Management of the HIV infected patient and antiretroviral pharmacotherapy
Antibacterial drug utilization, resistance, and appropriate prescribing
Antimicrobial Stewardship
Current Duke Appointments & Affiliations
Professor in Medicine
·
2022 - Present
Medicine, Infectious Diseases,
Medicine
Recent Scholarly Works
Comprehensive Review of Candidozyma (Candida) auris Management: Insights From the Society of Infectious Diseases Pharmacists.
Journal article Pharmacotherapy · April 2026 Candidozyma (Candida) auris has emerged over the past two decades as a formidable global health threat due to its multidrug resistance, persistence in healthcare environments, and rapid nosocomial spread. Recently reclassified into the genus Candidozyma ba ... Full text Link to item CiteImpact of a Targeted Stewardship Intervention to Optimize Antibiotics in Patients Prescribed Aztreonam in a Community Hospital in the Duke Antimicrobial Stewardship Outreach Network (DASON)
Conference AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY · March 6, 2026 Link to item CiteMUC16-dependent Renal Vascular Adhesion of Candida Promotes Tissue Invasion and Predicts Clinical Outcome in Candidemia.
Journal article Res Sq · March 4, 2026 Bloodstream infection with Candida species is associated with high mortality, yet the molecular basis of vascular adhesion and invasion remains unclear. We identify the endothelial surface mucin MUC16 as a key host factor enabling fungal vascular adherence ... Full text Link to item CiteRecent Grants
Tri-Institutional Molecular Mycology and Pathogenesis Training Program
Inst. Training Prgm or CMEMentor · Awarded by National Institute of Allergy and Infectious Diseases · 2024 - 2029Systems Biology for Infectious Diseases
ResearchPrincipal Investigator · Awarded by The Lundquist Institute · 2023 - 2028Host directed medicine in invasive fungal infection - HDM-FUN
Clinical TrialCo Investigator · Awarded by European Union · 2020 - 2026View All Grants
Education
Duke University, School of Medicine ·
2007
M.H.S.
Campbell University ·
1997
Pharm.D.
Duke University, School of Medicine ·
1992
B.S.